UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Inogen
INGN
$164M
| $627K | ﹤0.01% |
17,654
+2,678
| +18% | +$113K |
|
|
CNST
1977
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $627K | ﹤0.01% |
+20,852
| New | +$751K |
|
1978
Simulations Plus
SLP
$371M
| $626K | ﹤0.01% |
+10,467
| New | +$461K |
|
|
SILV
1979
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $625K | ﹤0.01% |
68,400
+4,200
| +7% | +$31.6K |
|
1980
QuinStreet
QNST
$1.21B
| $625K | ﹤0.01% |
59,758
-2,204
| -4% | -$21.3K |
|
1981
Woori Financial
WF
$17.6B
| $625K | ﹤0.01% |
+28,192
| New | +$592K |
|
|
OSG
1982
Octave Specialty Group
OSG
$222M
| $624K | ﹤0.01% |
43,600
-10,601
| -20% | -$155K |
|
1983
Kura Oncology
KURA
$850M
| $623K | ﹤0.01% |
38,240
+22,724
| +146% | +$328K |
|
1984
Unisys
UIS
$217M
| $623K | ﹤0.01% |
57,119
-1,526
| -3% | -$17.6K |
|
|
SAFE
1985
DELISTED
Safehold Inc.
SAFE
| $621K | ﹤0.01% |
10,800
| – | – |
|
|
PING
1986
DELISTED
Ping Identity Holding Corp.
PING
| $619K | ﹤0.01% |
+19,300
| New | +$511K |
|
1987
Omeros
OMER
$959M
| $618K | ﹤0.01% |
41,957
+2,308
| +6% | +$34.5K |
|
|
MAGN
1988
Magnera Corp
MAGN
$460M
| $617K | ﹤0.01% |
2,955
+1,120
| +61% | +$212K |
|
|
PETQ
1989
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $611K | ﹤0.01% |
17,538
+6,638
| +61% | +$186K |
|
|
MEET
1990
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $608K | ﹤0.01% |
+97,495
| New | +$600K |
|
1991
Lindsay Corp
LNN
$1.18B
| $605K | ﹤0.01% |
6,560
-35
| -0.5% | -$3.21K |
|
1992
Tucows
TCX
$175M
| $600K | ﹤0.01% |
10,473
+4,648
| +80% | +$258K |
|
|
RAVN
1993
DELISTED
Raven Industries Inc
RAVN
| $599K | ﹤0.01% |
27,832
-1,209
| -4% | -$25.5K |
|
1994
Kearny Financial
KRNY
$599M
| $598K | ﹤0.01% |
73,124
-6,898
| -9% | -$57.8K |
|
1995
Buckle
BKE
$2.37B
| $598K | ﹤0.01% |
38,146
+1,568
| +4% | +$23.5K |
|
|
LBAI
1996
DELISTED
Lakeland Bancorp Inc
LBAI
| $597K | ﹤0.01% |
52,246
-2,372
| -4% | -$25.5K |
|
|
TVRD
1997
Tvardi Therapeutics
TVRD
$23.4M
| $597K | ﹤0.01% |
970
+89
| +10% | +$49.2K |
|
1998
RadNet
RDNT
$5.69B
| $597K | ﹤0.01% |
37,615
+4,609
| +14% | +$66.7K |
|
|
CONN
1999
DELISTED
Conn's Inc.
CONN
| $595K | ﹤0.01% |
59,000
-17,535
| -23% | -$116K |
|
2000
Levi Strauss
LEVI
$9.39B
| $594K | ﹤0.01% |
44,347
+6,400
| +17% | +$84K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.